Braseth Turid Aarhus, Hervig Tor, Rosvik Anne Synnove
Faculty of Engineering and Business Administration, Department of Biomedical Laboratory Sciences and Chemical Engineering, Bergen University College, pb 7030, 5020 Bergen, Norway; Western Norway University of Applied Sciences, Postbox 7030, 5020 Bergen, Norway.
Institute of Clinical Sciences, University of Bergen, 5021 Bergen, Norway; Department of Immunology and transfusion medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Transfus Apher Sci. 2017 Jun;56(3):485-489. doi: 10.1016/j.transci.2017.05.012. Epub 2017 May 18.
The voluntary, unpaid, altruistic blood donor is a cornerstone of current transfusion medicine. The complexity of medical and ethical issues related to blood donation and hemochromatosis has led to a large number of studies related to the safety of the hemochromatosis donor and the quality of the blood components produced from these donations. The issue of accepting persons with HC as blood donors is diverting, both in Europe and worldwide and without joint guidelines. A questionnaire-based study was performed and mailed to all 25 blood bank leaders in Norway. Descriptive analysis was used to evaluate the data. Eight of 22 blood banks strictly followed national guidelines concerning persons with hemochromatosis. Other blood banks make local adjustments. 16 of 22 responding blood banks accept hemochromatosis donors and five do not, and one answered partly yes. The reasons the blood bank leaders supported the acceptance of hemochromatosis donors differ. Based on published papers and the present questionnaire, we believe that a clear definition of the "hemochromatosis donor" and guidelines with more detailed information on an acceptable donation regime would be important to overcome the weak points in blood donor eligibility criteria.
自愿无偿献血者是当前输血医学的基石。与献血和血色素沉着症相关的医学和伦理问题的复杂性导致了大量关于血色素沉着症献血者安全性以及这些献血所产生血液成分质量的研究。在欧洲乃至全球，接受血色素沉着症患者作为献血者的问题存在分歧，且没有统一的指导方针。我们开展了一项基于问卷调查的研究，并将问卷邮寄给了挪威所有25位血库负责人。采用描述性分析来评估数据。22家血库中有8家严格遵循关于血色素沉着症患者的国家指导方针。其他血库则进行了局部调整。22家回复的血库中，16家接受血色素沉着症献血者，5家不接受，1家部分接受。血库负责人支持接受血色素沉着症献血者的原因各不相同。基于已发表的论文和本次问卷调查，我们认为明确“血色素沉着症献血者”的定义以及制定关于可接受献血制度的更详细信息的指导方针，对于克服献血者资格标准中的薄弱环节至关重要。
